253
5
2
171
Cat. No. | Product Name | Form | Specificity Of Inhibition |
---|---|---|---|
CL0058 |
EGFR inhibitor kit
EGFR inhibitor kit |
||
CL0068 |
VEGFR inhibitor kit
VEGFR inhibitor kit |
Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
TP1807 |
EGF Receptor Substrate 2 Phospho-Tyr5
|
||
EGF Receptor Substrate 2 (Phospho-Tyr5) is a biologically active peptide derived from an autophosphorylation site (Tyr992) of EGFR. | |||
T3506 |
Nazartinib
那扎替尼,EGF816,NVS-816 |
EGFR | Angiogenesis; JAK/STAT signaling; Tyrosine Kinase/Adaptors |
Nazartinib (EGF816) 是一种共价、不可逆、突变选择性 EGFR 抑制剂,对激活 mt (L858R, ex19del) 和 T790M mt 具有纳摩尔抑制效力,在体外其选择性比野生型 (wt) EGFR 高 60 倍。 | |||
T75764 | EGF Receptor Substrate 2 (Phospho-Tyr5) | ||
EGFReceptor Substrate 2 (Phospho-Tyr5) 是一种活性肽,它来源于表皮生长因子受体自身磷酸化位点 (酪氨酸992)。 | |||
T14004 |
1A-116
|
Rho | Cell Cycle/Checkpoint |
1A-116 是 Rac1的抑制剂,对几种类型的癌症具有抗肿瘤和抗转移作用,如乳腺癌。 | |||
T8574 |
SPHINX
|
Others | Others |
SPHINX 是新一代的 SPRK1抑制剂。 | |||
T76472 |
EGF-R (661-681) T669 Peptide
|
||
EGF-R (661-681) T669 Peptide 是一种 MAPK 底物,可用于测量 MAPK 催化活性。 | |||
T9927 |
Panitumumab
|
EGFR | Angiogenesis; JAK/STAT signaling; Tyrosine Kinase/Adaptors |
Panitumumab 是一种重组全人源 IgG2 单克隆抗体,可与表皮生长因子(EGFR)结合,具有抗肿瘤活性。 | |||
T11156L |
Nazartinib mesylate
EGF816 (mesylate) |
Others | Others |
Nazartinib mesylate is a novel, covalent mutant-selective inhibitor of EGFR (Ki and Kinact: 31 nM and 0.222/min on EGFR(L858R/790M) mutant). | |||
T11156 |
Nazartinib S-enantiomer
EGF816 (S-enantiomer) |
Others | Others |
Nazartinib is an EGFR inhibitor. Nazartinib S-enantiomer is the less active S-enantiomer of Nazartinib. | |||
T37078 |
VEGFR-2-IN-6
|
VEGFR | Angiogenesis; Tyrosine Kinase/Adaptors |
VEGFR-2-IN-6(WO 02/059110)是一种 VEGFR2 的强效抑制剂,这是一种在血管生成调控中起关键作用的受体[1]。 | |||
T79888 |
EGFR-IN-87
|
EGFR | Angiogenesis; JAK/STAT signaling; Tyrosine Kinase/Adaptors |
EGFR-IN-87 为EGFR酪氨酸激酶抑制剂,针对A431细胞中EGFR_d746-750, EGFR_L858R/T790M 及 EGFR_WT 具有IC50值分别约为3.1 nM、1.3 nM和7.1 nM,适用于癌症疾病研究。 | |||
T2056 |
VEGFR-2-IN-5
2, 4-Pyrimidinediamine with linker,UNC0064-12,2,4-Pyrimidinediamine with linker |
VEGFR | Angiogenesis; Tyrosine Kinase/Adaptors |
VEGFR-2-IN-5 (UNC0064-12) 是 VEGFR2 抑制剂。 | |||
T21954 |
EGFR/ErbB-2/ErbB-4 inhibitor-2
EGFR/ErbB2 Inhibitor |
EGFR | Angiogenesis; JAK/STAT signaling; Tyrosine Kinase/Adaptors |
EGFR/ErbB-2/ErbB-4 inhibitor-2 (EGFR/ErbB2 Inhibitor) 是EGFR 和ErbB 的抑制剂,对EGFR、ErbB2 和 ErbB4 的IC50分别为 0.017、0.08 和 1.91 μM。 | |||
T4288 |
hVEGF-IN-1
|
VEGFR | Angiogenesis; Tyrosine Kinase/Adaptors |
hVEGF-IN-1 是一种喹唑啉衍生物,可以特异性结合内部核糖体进入位点 A 中富含 G 的序列,并会使 G-四链体结构不稳定。在 SPR 实验中,它与 IRES-A (WT) 结合的Kd 值为 0.928 μM。它能够抑制VEGF-A 蛋白表达,阻止肿瘤细胞迁移,抑制肿瘤生长。 | |||
T79860 |
TIE-2/VEGFR-2 kinase-IN-5
|
VEGFR; Tie-2 | Angiogenesis; Tyrosine Kinase/Adaptors |
TIE-2/VEGFR-2 kinase-IN-5 是一种高效的 TIE-2 和 VEGFR-2 酪氨酸激酶受体抑制剂,具有的抗血管生成活性,常用于血管生成相关的生物医学研究领域。 | |||
T10802 |
CHMFL-EGFR-202
|
EGFR | Angiogenesis; JAK/STAT signaling; Tyrosine Kinase/Adaptors |
CHMFL-EGFR-202 是一种有效、不可逆的表皮生长因子受体 (EGFR) 突变型激酶抑制剂, 对耐药突变型 EGFR T790M 和 WT EGFR 激酶作用的 IC50 分别为 5.3 nM 和 8.3 nM。 | |||
T11158 |
EGFR-IN-11
|
EGFR | Angiogenesis; JAK/STAT signaling; Tyrosine Kinase/Adaptors |
EGFR-IN-11 是 EGFR-酪氨酸激酶的选择性抑制剂,可诱导细胞凋亡。 EGFR-IN-11 抑制三重突变体 EGFRL858R/T790M/C797S,IC50 为 18 nM,并在 G0/G1 时阻止细胞周期。 | |||
T11161 |
EGFR-IN-7
TQB3804 |
EGFR | Angiogenesis; JAK/STAT signaling; Tyrosine Kinase/Adaptors |
EGFR-IN-7 (TQB3804) 是一种有效选择性的EGFR 激酶抑制剂,对 EGFR (WT) 和 EGFR (mutant C797S/T790M/L858R) 的IC50值分别为 7.92 和 0.218 nM,具有抗肿瘤活性。 | |||
T5168 |
EGFR-IN-12
EGFR Inhibitor |
Apoptosis; EGFR | Angiogenesis; Apoptosis; JAK/STAT signaling; Tyrosine Kinase/Adaptors |
EGFR-IN-12 (EGFR Inhibitor) 是一种 4,6-二取代的嘧啶,可诱导细胞凋亡,具有抗肿瘤活性。它是ATP 竞争性,不可逆且高度选择性的EGFR 抑制剂,IC50为 21 nM。它对EGFR 的选择性高于 HER4 和 55种其他激酶。它还抑制突变型EGFRL858R 和EGFRL861Q,IC50分别为 63 nM 和 4 nM。 | |||
T79861 |
EGFR/ErbB-2 inhibitor-1
|
EGFR | Angiogenesis; JAK/STAT signaling; Tyrosine Kinase/Adaptors |
EGFR/ErbB-2 inhibitor-1 是一种选择性的 ErbB2/HER2 抑制剂,能有效地阻断ErbB2和HER2的信号传导。 | |||
T63732 |
EGFR-IN-3
|
Apoptosis; EGFR | Angiogenesis; Apoptosis; JAK/STAT signaling; Tyrosine Kinase/Adaptors |
EGFR-IN-3 是一种 EGFR 抑制剂,具有潜在的抗肿瘤活性。EGFR-IN-3 抑制 EGFRwt-TK,诱导细胞凋亡 (apoptosis),可使细胞在G2/M期阻滞。 | |||
T11160 |
EGFR-IN-5
|
EGFR | Angiogenesis; JAK/STAT signaling; Tyrosine Kinase/Adaptors |
EGFR-IN-5 是 EGFR 的特异性抑制剂。 EGFR、EGFR(L858R)、EGFR(L858R/T790M) 和 EGFR(L858R/T790M/C797S) 的 IC50 分别为 10.4、1.1、34、7.2 nM。 | |||
T61899 |
VEGFR2-IN-1
|
VEGFR | Angiogenesis; Tyrosine Kinase/Adaptors |
VEGFR2-IN-1 是一种具有选择性和高效性的 VEGFR2 抑制剂,具有抗肿瘤活性,可抑制细胞的增殖和迁移,可用于研究乳腺癌。 | |||
T72924 |
VEGFR-3-IN-1
|
VEGFR | Angiogenesis; Tyrosine Kinase/Adaptors |
VEGFR-3-IN-1 是一种新型有效且具有选择性的 VEGFR3 抑制剂,其 IC50 为 110.4 nM。VEGFR-3-IN-1 具有抗肿瘤活性,可使 VEGFR3 信号通路失活,可抑制 VEGF-C 诱导人真皮淋巴管内皮细胞 (HDLEC)、MDA-MB-231 和 MDA-MB-436 细胞的增殖和迁移,并且能有效抑制乳腺癌的生长。 | |||
T75120 |
EGFR-IN-76
|
EGFR | Angiogenesis; JAK/STAT signaling; Tyrosine Kinase/Adaptors |
EGFR-IN-76 是 一种有有效的 EGFR 抑制剂。 | |||
T16162 |
Mutated EGFR-IN-1
Osimertinib analog,AZD9291中间体1 |
EGFR | Angiogenesis; JAK/STAT signaling; Tyrosine Kinase/Adaptors |
Mutated EGFR-IN-1 (Osimertinib analog) 是用于突变 EGFR 抑制剂设计的有用中间体,例如 L858R EGFR、Exon19 缺失激活突变体和 T790M 抗性突变体。 | |||
T35901 |
EGFR-IN-99
JBJ-03-142-02 |
EGFR; HER | Angiogenesis; JAK/STAT signaling; Tyrosine Kinase/Adaptors |
EGFR-IN-99 (JBJ-03-142-02) 是一种 EGFR 和 HER2 Exon 20 插入突变抑制剂,具有抗增殖活性,可用于研究非小细胞肺癌 (NSCLC) 。 | |||
T9979 |
VEGFR-2-IN-29
|
VEGFR | Angiogenesis; Tyrosine Kinase/Adaptors |
VEGFR-2-IN-29是一种 VEGFR2抑制剂。 | |||
T2705 |
Mutant EGFR inhibitor
|
EGFR | Angiogenesis; JAK/STAT signaling; Tyrosine Kinase/Adaptors |
Mutant EGFR inhibitor 是选择性EGFR 突变体抑制剂,可抑制EGFRL858R、EGFRExon 19 deletion 和EGFRT790M。 | |||
T11162 |
EGFR-IN-8
|
EGFR; c-Met/HGFR | Angiogenesis; JAK/STAT signaling; Tyrosine Kinase/Adaptors |
EGFR-IN-8 是 EGFR 和 c-Met 的双重抑制剂。 EGFR-IN-8可用于靶向 EGFR TKI 耐药的 NSCLC 的研究。 | |||
T11157L |
EGFR-IN-1 hydrochloride
|
EGFR | Angiogenesis; JAK/STAT signaling; Tyrosine Kinase/Adaptors |
EGFR-IN-1 hydrochloride 是 L858R/T790M 突变体 EGFR 的不可逆特异性抑制剂,选择性是野生型 EGFR 的 100 倍。 EGFR-IN-1 hydrochloride 在 H1975 细胞和突变体 HCC827 细胞中表现出有效的抗肿瘤和抗增殖活性,IC50 分别为 4 和 28 nM。 | |||
T11163 |
EGFR-IN-9
|
EGFR | Angiogenesis; JAK/STAT signaling; Tyrosine Kinase/Adaptors |
EGFR-IN-9 是一种有效的 EGFR 激酶抑制剂,对于野生型 EGFR 激酶和双重突变型 EGFR 激酶 (L858R/T790M) 的 IC50 分别为 7 nM 和 28 nM。EGFR-IN-9 具有抗肿瘤活性。 | |||
T9724 |
VEGFR2-IN-2
|
Others | Others |
VEGFR2-IN-2 具有抗炎和镇痛活性。 | |||
T78849 |
EGFR/BRAFV600E-IN-2
|
EGFR | Angiogenesis; JAK/STAT signaling; Tyrosine Kinase/Adaptors |
E07 aptamer是靶向人表皮生长因子受体(hEGFR)的适配体,能与EGF竞争性结合至EGFR的新表位。该适配体与表达hEGFR的细胞互作,阻断受体自磷酸化作用,抑制肿瘤细胞在三维基质中的增殖,适用于肿瘤病理研究。 | |||
T75261 | EGFR-IN-1 TFA | ||
EGFR-IN-1 TFA 是一种口服活性不可逆的突变型选择性 L858R/T790MEGFR 抑制剂。与野生型 EGFR 相比,EGFR-IN-1 TFA 对 Gefitinib 耐药的 EGFRL858R/T790M 有 100 倍的抑制作用。EGFR-IN-1 TFA 对 H1975 细胞和 HCC827 细胞具有较强的抗增殖活性。具有抗肿瘤活性。 | |||
T63556 | EGFR-IN-59 | ||
EGFR-IN-59 是 EGFR 抑制剂,其IC50值为190 nM,也是一直凋亡 (apoptosis) 诱导剂。EGFR-IN-59 对非小肺癌细胞系 (A549) 和正常肺成纤维细胞 (WI38) 表现出细胞毒性的IC50分别为 8.62 和 52.6 μM。EGFR-IN-59 能够用于研究非小细胞肺癌 (NSCLC)、头颈癌、乳腺癌和结直肠癌等多种癌症。 | |||
T64255 | EGFR-IN-48 | ||
EGFR-IN-48 是一种有效的、口服具有活力的 EGFR 抑制剂,能够作用于 EGFRd19/TM/CS (IC50: 0.193 nM)、EGFRLR/TM/CS (IC50: 0.251 nM)、EGFRWT (IC50: 10.4 nM)。EGFR-IN-48 也能够抑制 BaF3EGFR del19/T790M/C797S 细胞 (IC50: 1.526 nM) 和 PC-9EGFR del19/T790M/C797S 细胞 (IC50: 66.7 nM)的增殖。 | |||
T73995 | EGFR/CSC-IN-1 | EGFR | Angiogenesis; JAK/STAT signaling; Tyrosine Kinase/Adaptors |
EGFR/CSC-IN-1为针对三阴性乳腺癌研究的潜在EGFR(IC50为10.52 nM)及肿瘤干细胞(CSC)双重抑制剂。 | |||
T78574 | EGFR-IN-85 | EGFR | Angiogenesis; JAK/STAT signaling; Tyrosine Kinase/Adaptors |
EGFR-IN-85(Compound 1)为EGFR抑制剂,对EGFRvⅢ磷酸化具有0.19 μM的IC50。本化合物可抑制肿瘤内EGFR信号传导,适用于恶性胶质瘤(GBM)研究。 | |||
T61596 | EGFR/HER2/DHFR-IN-1 | ||
EGFR/HER2/DHFR-IN-1 is a highly selective and potent anticancer compound specifically targeting MCF-7 breast cancer cells. It acts as a multi-inhibitor, targeting the EGFR/HER2 kinase and DHFR enzymes, with IC50 values of 0.153 μM, 0.108 μM, and 0.291 μM, respectively. Its mechanism of action involves cell cycle arrest at the G1/S phase and induction of apoptosis in cells [1]. | |||
T76697 | Panitumumab (anti-EGFR) | ||
Panitumumab (anti-EGFR) 是一种全人源IgG2抗EGFR 单克隆抗体,具有抗肿瘤活性。Panitumumab (anti-EGFR) 抑制肿瘤细胞增殖、存活和血管生成。Panitumumab (anti-EGFR) 可用于癌症研究,例如结肠癌。 | |||
T61696 | EGFR-IN-57 | ||
EGFR-IN-57 (Compound 25a) 是一种有效的、具有口服活性的EGFR-TK 抑制剂,IC50值为 0.054 μM。EGFR-IN-57 也抑制VEGFR-2、CK2α、topoisomerase IIβ和tubulin polymerization,IC50值分别为 0.087、0.171、0.13 和 3.61 μM。EGFR-IN-57 诱导细胞 G2/M 和 pre-G1 期周期阻滞,诱导癌细胞凋亡 (apoptosis)。 | |||
T73178 | EGFR-IN-75 | ||
EGFR-IN-75 是一种EGFRWT 和EGFRT790M 抑制剂,IC50值分别为 0.28 μM 和 5.02 μM。EGFR-IN-75 具有抗癌和抗氧化活性。 | |||
T74833 | EGFR T790M/L858R-IN-2 | ||
EGFRT790M/L858R-IN-2是一种有效选择性的EGFRT790M/L858R抑制剂,其对EGFRT790M/L858R和EGFRWT的IC50值分别为3.5nM和1290nM。该化合物能够降低p-EGFR、P-AKT、P-ERK1/2的表达,诱导细胞凋亡及细胞周期在G1期的停滞,显示出抗癌活性。 | |||
T11157 |
EGFR-IN-1
|
EGFR | Angiogenesis; JAK/STAT signaling; Tyrosine Kinase/Adaptors |
EGFR-IN-1, an orally active and irreversible selective inhibitor targeting L858R/T790M mutant EGFR, exhibits strong antiproliferative and antitumor activity, particularly against H1975 cells and first line mutant HCC827 cells. This compound potently inhibits Gefitinib-resistant EGFR L858R/T790M mutations with a 100-fold selectivity over the wild-type EGFR. | |||
T79386 |
EGFR-IN-84
|
EGFR | Angiogenesis; JAK/STAT signaling; Tyrosine Kinase/Adaptors |
EGFR-IN-84 (Compound 6g),作为EGFR抑制剂(IC50: 24 nM),对A549细胞生长表现出抑制作用(IC50: 1.537 μM),适用于肺癌研究。 | |||
T79540 |
hCA/VEGFR-2-IN-1
|
Carbonic Anhydrase | Metabolism |
hCA/VEGFR-2-IN-1 是一种高效的双靶点抑制剂,对 hCA IX 和 hCA XII 两种碳酸酐酶(CA)具有极低的Ki值,分别为8.3 nM和4.7 nM。同时,hCA/VEGFR-2-IN-1 也是一种有效的 VEGFR-2 抑制剂,其 IC50 值仅为26.3 nM,并且显示出抗癌活性。 | |||
T72713 |
PI3K/VEGFR2-IN-1
|
PI3K | PI3K/Akt/mTOR signaling |
PI3K/VEGFR2-IN-1是一种具有双重抑制效应的化合物,对PI3K和VEGFR2的IC50分别为2.21 μM和68 μM,能够诱导细胞凋亡(apoptosis),在癌症研究中应用。 | |||
T62746 |
EGFR/HER2/CDK9-IN-1
|
||
EGFR/HER2/CDK9-IN-1 (Compound 4) 是一种有效的 EGFR/HER2/CDK9 抑制剂,他们的 IC50 值分别为 90.17、131.39 和 67.04 nM。EGFR/HER2/CDK9-IN-1 表现出明显的抗肿瘤作用。 | |||
T62457 |
EGFR-IN-54
|
||
EGFR-IN-54 (Compound 3c) 是一种 EGFR 的有效抑制剂 (IC50: 1.623 μM),对癌细胞具有毒性。 |
Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T22974 |
Methyl 2,5-dihydroxycinnamate
|
EGFR | Angiogenesis; JAK/STAT signaling; Tyrosine Kinase/Adaptors |
Methyl 2,5-dihydroxycinnamate 是 erbstatin 类似物,是一种高效、稳定的 EGF 受体相关酪氨酸激酶的抑制剂。 | |||
T4S0878 |
Prunetin
樱黄素,Prunusetin |
ERK; Dehydrogenase; NF-κB | MAPK; Metabolism; NF-κB |
Prunetin (Prunusetin) 是一种O-甲基化异黄酮,具有抗炎的作用。它是人醛脱氢酶的有效抑制剂。 | |||
T2988 |
(-)-Epigallocatechin Gallate
Epigallocatechol Gallate,(-)-表没食子儿茶素没食子酸酯,EGCG |
Ferroptosis; Reactive Oxygen Species; HIV Protease; Mitochondrial Metabolism; Endogenous Metabolite; Autophagy | Apoptosis; Autophagy; Immunology/Inflammation; Metabolism; Microbiology/Virology; NF-κB; Proteases/Proteasome |
(-)-Epigallocatechin Gallate (EGCG) 是茶类黄酮,具有强大的抗氧化,抗炎和抗癌作用。它可抑制EGFR 信号传导,有抗癌作用。它是谷氨酸脱氢酶 1/2 抑制剂。它通过激活细胞色素c 氧化酶来诱导氧化磷酸化。 | |||
T2995 |
Chrysophanol
大黄酚,3-Methylchrysazin,Chrysophanic Acid,Turkey Rhubarb |
EGFR | Angiogenesis; JAK/STAT signaling; Tyrosine Kinase/Adaptors |
Chrysophanol (Turkey Rhubarb) 是掌叶大黄中的一种蒽醌类天然产物,可抑制EGF-诱导的EGFR 磷酸化,且抑制AKT 和mTOR/p70S6K 激活。 | |||
T6427 |
Butein
2’,3,4,4’-tetrahydroxy Chalcone,紫铆因 |
Apoptosis; EGFR; Others; PDE; Autophagy | Angiogenesis; Apoptosis; Autophagy; JAK/STAT signaling; Metabolism; Others; Tyrosine Kinase/Adaptors |
Butein (2’,3,4,4’-tetrahydroxy Chalcone) 是一种 cAMP 特异性PDE 抑制剂,也是蛋白酪氨酸激酶抑制剂,还是一种SIRT1激活剂。它通过 AKT 和 ERK/p38 MAPK 通路,靶向 FoxO3a 使 HeLa 细胞对 Cisplatin 敏感。 |
Cat. No. | Product Name | Species | Expression System |
---|---|---|---|
TMPY-01560 |
EGF Protein, Human, Recombinant
URG,epidermal growth factor,表皮生长因子,HOMG4 |
Human | E. coli |
EGF Protein, Human, Recombinant is expressed in E. coli expression system. The predicted molecular weight is 6.35 kDa and the accession number is P01133-1. | |||
TMPY-06984 |
EGF Protein, Mouse, Recombinant (Yeast)
表皮生长因子,AI790464,epidermal growth factor |
Mouse | P. pastoris (Yeast) |
EGF Protein, Mouse, Recombinant (Yeast) is expressed in yeast. The predicted molecular weight is 6 KDa. and the accession number is P01132. | |||
TMPY-02246 |
HB-EGF Protein, Human, Recombinant
DTSF,DTR,HEGFL,heparin-binding EGF-like gr... |
Human | Baculovirus Insect Cells |
Heparin-binding EGF-like growth factor (HBEGF), a member of the EGF family of growth factors, exerts its biological activity through activation of the EGFR and other ErbB receptors. Soluble mature HBEGF is proteolytically processed from a larger membrane-anchored precursor and is a potent mitogen and chemotactic factor for fibroblasts, smooth muscle cells but not endothelial cells. HBEGF activates two EGF receptor subtypes, HER1 and HER4, and binds to cell surface HSPG. The transmembrane form of... | |||
TMPJ-01286 |
proHB-EGF Protein, Human, Recombinant (His)
heparin-binding EGF-like growth factor,HB-EGF |
Human | HEK293 Cells |
Heparin-binding EGF-like growth factor (HB-EGF) is a 1216 kDa member of the epidermal growth factor (EGF) family. It possesses an EGFlike domain, and a heparin-binding motif. Mature HBEGF is a soluble peptide that arises from proteolytic processing of the transmembrane form. Human HBEGF shows 76% and 73% aa sequence identity with rat and mouse HBEGF, respectively. It is required for normal cardiac valve formation and normal heart function, promotes smooth muscle cell proliferation. It may b... | |||
TMPY-01062 |
EGF Protein, Human, Recombinant (hFc)
Epidermal Growth Factor,表皮生长因子,URG,HOMG4 |
Human | HEK293 Cells |
EGF Protein, Human, Recombinant (hFc) is expressed in HEK293 mammalian cells with hFc tag. The predicted molecular weight is 33 kDa and the accession number is P01133-1. | |||
TMPY-02836 |
MFGE8 Protein, Human, Recombinant (His)
SPAG10,HMFG,milk fat globule-EGF factor 8 protein,h... |
Human | Baculovirus Insect Cells |
MFGE8 Protein, Human, Recombinant (His) is expressed in Baculovirus insect cells with His tag. The predicted molecular weight is 42 kDa and the accession number is Q08431-1. | |||
TMPY-05162 |
MEGF10 Protein, Human, Recombinant (hFc)
EMARDD,multiple EGF-like-domains 10 |
Human | HEK293 Cells |
MEGF10 Protein, Human, Recombinant (hFc) is expressed in HEK293 mammalian cells with hFc tag. The predicted molecular weight is 90.2 kDa and the accession number is XP_016865476.1. | |||
TMPY-02539 |
EGF Protein, Canine, Recombinant (His)
epidermal growth factor,表皮生长因子 |
Canine | E. coli |
EGF Protein, Canine, Recombinant (His) is expressed in E. coli expression system with His tag. The predicted molecular weight is 8.3 kDa and the accession number is Q9BEA0. | |||
TMPY-04301 |
MEGF10 Protein, Human, Recombinant (His)
EMARDD,multiple EGF-like-domains 10 |
Human | HEK293 Cells |
MEGF10 Protein, Human, Recombinant (His) is expressed in HEK293 mammalian cells with His tag. The predicted molecular weight is 90.2 kDa and the accession number is Q96KG7-1. | |||
TMPY-04647 |
EGFL6 Protein, Human, Recombinant (His & FLAG)
EGF-like-domain, multiple 6,MAEG,W80 |
Human | Baculovirus Insect Cells |
EGFL6 Protein, Human, Recombinant (His & FLAG) is expressed in Baculovirus insect cells with His and Flag tag. The predicted molecular weight is 61.5 kDa and the accession number is Q8IUX8-1. | |||
TMPY-04220 |
EGF Protein, Rat, Recombinant
epidermal growth factor |
Rat | E. coli |
EGF Protein, Rat, Recombinant is expressed in E. coli expression system. The predicted molecular weight is 6.3 kDa and the accession number is P07522. | |||
TMPY-04884 |
EGF Protein, Canine, Recombinant
epidermal growth factor,表皮生长因子 |
Canine | P. pastoris (Yeast) |
EGF Protein, Canine, Recombinant is expressed in yeast. The predicted molecular weight is 6.2 kDa and the accession number is Q9BEA0. | |||
TMPY-03701 |
EGF Protein, Mouse, Recombinant
|
Mouse | HEK293 Cells |
EGF Protein, Mouse, Recombinant is expressed in HEK293 mammalian cells. The predicted molecular weight is 6.2 kDa; 14 kDa, reducing conditions and the accession number is P01132. | |||
TMPY-03494 |
CRELD2 Protein, Mouse, Recombinant (His)
5730592L21Rik,cysteine-rich with EGF-like domains 2... |
Mouse | HEK293 Cells |
CRELD2 Protein, Mouse, Recombinant (His) is expressed in HEK293 mammalian cells with His tag. The predicted molecular weight is 37.5 kDa and the accession number is Q9CYA0. | |||
TMPY-03454 |
CRELD1 Protein, Mouse, Recombinant (His)
cysteine-rich with EGF-like domains 1,AI843811 |
Mouse | HEK293 Cells |
CRELD1 Protein, Mouse, Recombinant (His) is expressed in HEK293 mammalian cells with His tag. The predicted molecular weight is 37.7 kDa and the accession number is Q91XD7. | |||
TMPY-03780 |
EGFL6 Protein, Human, Recombinant (His)
W80,EGF-like-domain, multiple 6,MAEG |
Human | Baculovirus Insect Cells |
EGFL6 Protein, Human, Recombinant (His) is expressed in Baculovirus insect cells with His tag. The predicted molecular weight is 60.5 kDa and the accession number is Q8IUX8-1. | |||
TMPY-02178 |
EGFL7 Protein, Mouse, Recombinant (His)
Zneu1,VE-statin,EGF-like-domain, multiple 7 |
Mouse | Baculovirus Insect Cells |
EGFL7 Protein, Mouse, Recombinant (His) is expressed in Baculovirus insect cells with His tag. The predicted molecular weight is 29.8 kDa and the accession number is Q9QXT5-1. | |||
TMPY-04339 |
EGFL7 Protein, Human, Recombinant (His)
VE-STATIN,NEU1,EGF-like-domain, multiple 7,ZNEU1 |
Human | Baculovirus Insect Cells |
EGFL7 Protein, Human, Recombinant (His) is expressed in Baculovirus insect cells with His tag. The predicted molecular weight is 29.4 kDa and the accession number is A0A024R8F5. | |||
TMPY-00094 |
EGFL6 Protein, Mouse, Recombinant (hFc)
EGF-like-domain, multiple 6,MGC141463,Egfl... |
Mouse | HEK293 Cells |
EGFL6 Protein, Mouse, Recombinant (hFc) is expressed in HEK293 mammalian cells with hFc tag. The predicted molecular weight is 56.8 kDa and the accession number is Q9JJZ5. | |||
TMPY-00078 |
EGFL6 Protein, Mouse, Recombinant (His)
Egfl6,MGC141463,Maeg,EGF-like-domain, mult... |
Mouse | HEK293 Cells |
EGFL6 Protein, Mouse, Recombinant (His) is expressed in HEK293 mammalian cells with His tag. The predicted molecular weight is 31.5 kDa and the accession number is Q9JJZ5. | |||
TMPY-06493 |
EGF Protein, Feline, Recombinant (hFc)
表皮生长因子,epidermal growth factor |
Feline | HEK293 Cells |
EGF Protein, Feline, Recombinant (hFc) is expressed in HEK293 mammalian cells with hFc tag. The predicted molecular weight is 34.63 kDa and the accession number is NP_001009381.1. | |||
TMPY-02267 |
EGF Protein, Mouse, Recombinant (hFc)
表皮生长因子,epidermal growth factor,AI790464 |
Mouse | HEK293 Cells |
EGF Protein, Mouse, Recombinant (hFc) is expressed in HEK293 mammalian cells with hFc tag. The predicted molecular weight is 34.5 kDa and the accession number is P01132. | |||
TMPY-00220 |
EGF Protein, Mouse, Recombinant (His)
epidermal growth factor,AI790464,表皮生长因子 |
Mouse | HEK293 Cells |
EGF Protein, Mouse, Recombinant (His) is expressed in HEK293 mammalian cells with His tag. The predicted molecular weight is 111.3 kDa and the accession number is AAH60741.1. | |||
TMPY-00420 |
CRELD1 Protein, Mouse, Recombinant (hFc)
cysteine-rich with EGF-like domains 1,AI843811 |
Mouse | HEK293 Cells |
CRELD1 Protein, Mouse, Recombinant (hFc) is expressed in HEK293 mammalian cells with hFc tag. The predicted molecular weight is 63 kDa and the accession number is Q91XD7. | |||
TMPY-00448 |
CRELD2 Protein, Mouse, Recombinant (hFc)
5730592L21Rik,cysteine-rich with EGF-like domains 2... |
Mouse | HEK293 Cells |
CRELD2 Protein, Mouse, Recombinant (hFc) is expressed in HEK293 mammalian cells with hFc tag. The predicted molecular weight is 62.8 kDa and the accession number is Q9CYA0. | |||
TMPJ-01197 |
CRELD2 Protein, Human, Recombinant (His)
Cysteine-Rich With EGF-Like Domain Protein 2,CRELD2 |
Human | HEK293 Cells |
Cysteine-Rich with EGF-Like Domain Protein 2 (CRELD2) is a secreted protein that is a member of the CRELD family. Human CRELD2 is synthesized as a 353 amino acid precursor protein with a signal peptide, a highly conserved domain rich in glutamic acid and tryptophan (WE) and EGF-like repeats. CRELD2 is ubiquitously expressed in many tissues. CRELD2 may interact with CHRNA4 and regulate transport of α4-β2 neuronal acetylcholine receptor. In addition, CRELD2 could be a novel mediator in regulating ... | |||
TMPY-03218 |
CRELD1 Protein, Human, Recombinant (His)
cysteine-rich with EGF-like domains 1,CIRRIN,AVSD2 |
Human | HEK293 Cells |
CRELD1 Protein, Human, Recombinant (His) is expressed in HEK293 mammalian cells with His tag. The predicted molecular weight is 37.4 kDa and the accession number is A0A024R2G1. | |||
TMPH-02645 |
EGFL8 Protein, Mouse, Recombinant (His & Myc & SUMO)
Egfl8,Epidermal growth factor-like protein 8,Ng3, |
Mouse | E. coli |
N/A. EGFL8 Protein, Mouse, Recombinant (His & Myc & SUMO) is expressed in E. coli expression system with N-10xHis-SUMO and C-Myc tag. The predicted molecular weight is 49.0 kDa and the accession number is Q6GUQ1. | |||
TMPJ-00681 |
EDIL3 Protein, Human, Recombinant (His)
EGF-Like Repeats and Discoidin I-Like Domains 3,EDI... |
Human | HEK293 Cells |
EGF-Like Repeat and Discoidin I-Like Domain-Containing Protein 3 (EDIL3) is a 52 kDa extracellular matrix protein that is expressed by endothelial tissues during embryonic vascular development. EDIL3 becomes quiescent at the time of birth, and is no longer expressed in normal adult tissues. EDIL3 has been found to be re-expressed in a number of human tumors as well as in ischemic muscles and ischemic brain tissue, which may play an important role in adult angiogenesis. EDIL3 promotes adherence a... | |||
TMPY-01910 |
TIE1 Protein, Human, Recombinant (His)
tyrosine kinase with immunoglobulin-like and EGF-li... |
Human | HEK293 Cells |
Tyrosine kinase with immunoglobulin-like and EGF-like domains 1 also known as Tie1 is an angiopoietin receptor and is an orphan receptor tyrosine kinase that is expressed almost exclusively in endothelial cells and that is required for normal embryonic vascular development. The receptor tyrosine kinase Tie1 is expressed primarily in vascular endothelial cells. The receptor has also been detected in epithelial tumours in breast, thyroid and gastric cancers and in tumour cell lines where it appear... | |||
TMPY-02600 |
NRG1 beta 1 Protein, Human, Recombinant (EGF Domain, hFc)
neuregulin 1,HRGA,NRG1 β1,HGL,MST131,MSTP131,HRG,ARIA,NDF,GG... |
Human | HEK293 Cells |
NRG1 beta 1 Protein, Human, Recombinant (EGF Domain, hFc) is expressed in HEK293 mammalian cells with Fc tag. The predicted molecular weight is 36.7 kDa and the accession number is Q02297-6. | |||
TMPY-04202 |
Tomoregulin-1 Protein, Mouse, Recombinant (hFc)
M7365,transmembrane protein with EGF-like and two f... |
Mouse | HEK293 Cells |
TMEFF1 is a novel transmembrane protein, containing two follisatin domains and an epidermal growth factor-like region. The ectopic expression of TMEFF1 in brain cancer cells resulted in their growth inhibition. That TMEFF1 may behave as a tumor suppressor gene in brain cancers. TMEFF1 and TMEFF2 are putative transmembrane proteins comprised of one epidermal growth factor (EGF)-like domain and two follistatin-like domains. Both TMEFF1 and TMEFF2 are predominantly expressed in the brain. Tomoregul... | |||
TMPY-02719 |
NRG1 alpha Protein, Human, Recombinant (EGF Domain, hFc)
HRG1,NRG1-IT2,HRGA,NRG1 α,HGL,neuregulin 1,SMDF,MSTP131,NDF,... |
Human | HEK293 Cells |
NRG1 alpha Protein, Human, Recombinant (EGF Domain, hFc) is expressed in HEK293 mammalian cells with Fc tag. The predicted molecular weight is 35.8 kDa and the accession number is Q02297-1. | |||
TMPY-00112 |
Tomoregulin-1 Protein, Human, Recombinant (hFc)
TR-1,C9orf2,transmembrane protein with EGF-like and... |
Human | HEK293 Cells |
TMEFF1 is a novel transmembrane protein, containing two follisatin domains and an epidermal growth factor-like region. The ectopic expression of TMEFF1 in brain cancer cells resulted in their growth inhibition. That TMEFF1 may behave as a tumor suppressor gene in brain cancers. TMEFF1 and TMEFF2 are putative transmembrane proteins comprised of one epidermal growth factor (EGF)-like domain and two follistatin-like domains. Both TMEFF1 and TMEFF2 are predominantly expressed in the brain. Tomoregul... | |||
TMPY-05235 |
MFGE8 Protein, Human, Recombinant (His & Avi), Biotinylated
HsT19888,SPAG10,MFGM,MFG-E8,OAcGD3S,milk fat globule-EGF... |
Human | Baculovirus Insect Cells |
MFGE8 Protein, Human, Recombinant (His & Avi), Biotinylated is expressed in Baculovirus insect cells with His and Avi tag. The predicted molecular weight is 44.1 kDa and the accession number is Q08431.2. | |||
TMPJ-00448 |
NRG1 beta 1 Protein, Human, Recombinant (aa 2-246)
NRG1β,HGL,NDF,NRG1,HRGA,HRG1-beta 1,Pro-neuregulin-1,HRG1-β1... |
Human | E. coli |
Pro-neuregulin-1,Neuregulin-1 beta 1(NRG1) is a single-pass type I membrane protein and belongs to the neuregulin family .It contains 1 EGF-like domain and 1 Ig-like C2-type (immunoglobulin-like) domain. Direct ligand for ERBB3 and ERBB4 tyrosine kinase receptors. The protein concomitantly recruits ERBB1 and ERBB2 coreceptors, resulting in ligand-stimulated tyrosine phosphorylation and activation of the ERBB receptors. The multiple isoforms perform diverse functions such as inducing growth and ... | |||
TMPY-01717 |
VEGF164 Protein, Mouse, Recombinant
vascular endothelial growth factor A,Vpf,Vegf,血管内皮生... |
Mouse | Baculovirus Insect Cells |
VEGF164 Protein, Mouse, Recombinant is expressed in Baculovirus insect cells. The predicted molecular weight is 19.4 kDa and the accession number is Q00731-2. | |||
TMPY-01007 |
VEGFC Protein, Human, Recombinant (His)
血管内皮生长因子,LMPH1D,VEGF-C,Flt4-L,vascular endothelial ... |
Human | HEK293 Cells |
VEGFC Protein, Human, Recombinant (His) is expressed in HEK293 mammalian cells with His tag. The predicted molecular weight is 15.5 kDa and the accession number is P49767. | |||
TMPY-02361 |
VEGFR2/KDR Protein, Human, Recombinant (His)
VEGFR2,kinase insert domain receptor,VEGFR... |
Human | HEK293 Cells |
VEGFR2/KDR Protein, Human, Recombinant (His) is expressed in HEK293 mammalian cells with His tag. The predicted molecular weight is 84.6 kDa and the accession number is P35968-1. | |||
TMPJ-00412 |
VEGFR1/FLT-1 Protein, Human, Recombinant (hFc)
Vascular endothelial growth factor receptor 1,Vascular perme... |
Human | HEK293 Cells |
Human Vascular endothelial growth factor receptor 1(VEGFR-1, FLT-1) is a member of the the class III subfamily of receptor tyrosine kinases (RTKs) and Tyr protein kinase family and CSF-1/PDGF receptor subfamily. VEGFR-1 is widely expressed in human tissues including normal lung, placenta, liver, kidney, heart and brain tissues. It is specifically expressed in most of the vascular endothelial cellsand peripheral blood monocytes. VEGFR-1 contains seven Ig-like C2-type domains and one protein kinas... | |||
TMPY-04818 |
EGFR Protein, Cynomolgus, Recombinant (His)
epidermal growth factor receptor |
Cynomolgus | HEK293 Cells |
EGFR Protein, Cynomolgus, Recombinant (His) is expressed in HEK293 mammalian cells with His tag. The predicted molecular weight is 70.1 kDa and the accession number is A0A2K5WK39. | |||
TMPJ-00864 |
VEGF165 Protein, Human, Recombinant
Vascular Endothelial Growth Factor Isoform 165,血管内皮生长因子,V |
Human | HEK293 Cells |
Human Vascular endothelial growth factor (VEGF), also known as VEGF-A and vascular permeability factor (VPF), belongs to the platelet-derived growth factor family of cysteine-knot growth factors. It is a potent activator in vasculogenesis and angiogenesis both physiologically and pathologically. VEGF-A has 8 differently spliced isoforms, of which VEGF165 is the most abundant one. VEGF165 is a disulfide-linked homodimer consisting of two glycosylated 165 amino acid polypeptide chains. VEGF stimul... | |||
TMPY-02676 |
EGFR Protein, Mouse, Recombinant (His)
Errp,AI552599,Errb1,9030024J15Rik,wa2,Erbb,wa-2,Wa5,epiderma... |
Mouse | HEK293 Cells |
EGFR Protein, Mouse, Recombinant (His) is expressed in HEK293 mammalian cells with His tag. The predicted molecular weight is 70.8 kDa and the accession number is Q01279. | |||
TMPK-00823 |
VEGF165 Protein, Human, Recombinant (His & Avi)
血管内皮生长因子,RP1-261G23.1,MVCD1,MGC70609,VEGFA,VEGF... |
Human | HEK293 Cells |
Vascular endothelial growth factor (VEGF or VEGF-A), also known as vascular permeability factor (VPF), is a potent mediator of both angiogenesis and vasculogenesis in the fetus and adult. VEGF165 appears to be the most abundant and potent isoform, followed by VEGF121 and VEGF189. VEGF165 Protein, Human, Recombinant (His & Avi) is expressed in HEK293 mammalian cells with C-His-Avi tag. The predicted molecular weight is 22.2 kDa and the accession number is P15692-4. | |||
TMPY-03698 |
VEGF121b Protein, Human, Recombinant
MVCD1,VEGF,VPF,vascular endothelial growth factor A |
Human | HEK293 Cells |
VEGF121b Protein, Human, Recombinant is expressed in HEK293 mammalian cells. The predicted molecular weight is 34.10 kDa and the accession number is P15692-9. | |||
TMPY-03156 |
VEGFC Protein, Mouse/Rat, Recombinant (aa 108-223, His)
vascular endothelial growth factor C |
Mouse,Rat | HEK293 Cells |
VEGFC Protein, Mouse/Rat, Recombinant (aa 108-223, His) is expressed in HEK293 mammalian cells with His tag. The predicted molecular weight is 14.5 kDa and the accession number is P97953-1. | |||
TMPY-00742 |
EGFR Protein, Human, Recombinant (His)
mENA,NISBD2,ERBB1,HER1,PIG61,ERBB,epidermal growth factor re... |
Human | HEK293 Cells |
EGFR Protein, Human, Recombinant (His) is expressed in HEK293 mammalian cells with His tag. The predicted molecular weight is 69.8 kDa and the accession number is P00533-1. | |||
TMPY-01936 |
VEGFR3/FLT4 Protein, Mouse, Recombinant (His)
Flt-4,VEGFR-3,Chy,fms related tyrosine kinase 4,V |
Mouse | HEK293 Cells |
VEGFR3/FLT4 Protein, Mouse, Recombinant (His) is expressed in HEK293 mammalian cells with His tag. The predicted molecular weight is 86.4 kDa and the accession number is P35917-1. | |||
TMPY-04529 |
EGFR Protein, Human, Recombinant (aa 668-1210, His & GST)
epidermal growth factor receptor,PIG61,ERBB1,NISBD2,ERBB,HER... |
Human | Baculovirus Insect Cells |
EGFR Protein, Human, Recombinant (aa 668-1210, His & GST) is expressed in Baculovirus insect cells with His and GST tag. The predicted molecular weight is 89.1 kDa and the accession number is P00533-1. | |||
TMPY-00949 |
VEGFR3/FLT4 Protein, Human, Recombinant (His)
VEGFR-3,PCL,FLT41,VEGF Receptor 3,VEGF... |
Human | HEK293 Cells |
VEGFR3/FLT4 Protein, Human, Recombinant (His) is expressed in HEK293 mammalian cells with His tag. The predicted molecular weight is 86 kDa and the accession number is P35916-1. | |||
------------------------ 更多 ------------------------ |